News

125 pages Commercialization of digital health technologies Evolution of regulatory and reimbursement pathways Reimbursement and uptake in the United States Global reimbursement opportunities Evidence trends and payer requirements Drivers and barriers to adoption Life Sciences opportunities and partnerships Digital health stakeholders — including developers, policymakers, payers, and providers — are actively shaping and accelerating the adoption of digital health solutions. Leading life sciences companies now take a systematic approach to digital health investment, conducting portfolio wide value and feasibility assessments that span solution types to aid diagnosis, therapy, and monitoring, and invest in patient support ecosystems to improve access and the patient experience. In addition to products, digital product developers now offer health services as digital care providers or diagnostic laboratories, repurpose their platforms to deliver custom offerings for providers, employers, and life sciences companies, and adapt remote monitoring tools to support clinical development and patient support programs. Approval and reimbursement of digital tools is accelerating as payers recognize clinical utility and cost savings, of the more than 360 software-based digital therapies commercially available,140 prescription digital therapeutics (TX) are approved for patient use at home and over 220 therapies are used within digital care or in clinics.